{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T10:35:00Z","timestamp":1769250900271,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["201803010012"],"award-info":[{"award-number":["201803010012"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.thromres.2022.08.014","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T11:28:39Z","timestamp":1660822119000},"page":"157-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The short-term predictive value of CD4+ cells for combination therapy with high-dose dexamethasone and immunoglobulin in newly diagnosed primary immune thrombocytopenia patients"],"prefix":"10.1016","volume":"218","author":[{"given":"Hongyun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duolan","family":"Naren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangfeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danian","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.thromres.2022.08.014_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28075","article-title":"Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia","volume":"67","author":"Wang","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.thromres.2022.08.014_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10245332.2016.1219497","article-title":"Advances in the pathophysiology of primary immune thrombocytopenia","volume":"22","author":"Perera","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.thromres.2022.08.014_bb0015","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V100.4.1388.h81602001388_1388_1398","article-title":"Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation","volume":"100","author":"Roark","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.08.014_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10875-011-9643-2","article-title":"Bmi-1 regulates autoreactive CD4+ T cell survival in immune thrombocytopenia patients","volume":"32","author":"Ma","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.thromres.2022.08.014_bb0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/bjh.12480","article-title":"Cellular immune dysfunction in immune thrombocytopenia (ITP)","volume":"163","author":"McKenzie","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2022.08.014_bb0030","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3324\/haematol.2011.046417","article-title":"The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia","volume":"96","author":"Rocha","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2022.08.014_bb0035","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3324\/haematol.2010.038638","article-title":"Circulating CD4+CD161+CD196+ Th17 cells are not increased in immune thrombocytopenia","volume":"96","author":"Sollazzo","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.thromres.2022.08.014_bb0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.thromres.2013.04.025","article-title":"Involvement of levels of Toll like receptor-4 in monocytes, CD4+T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura","volume":"132","author":"Liu","year":"2013","journal-title":"Thromb. Res."},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2022.08.014_bb0045","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1053\/j.seminhematol.2016.04.006","article-title":"Imbalanced immune homeostasis in immune thrombocytopenia","volume":"53","author":"Yazdanbakhsh","year":"2016","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.thromres.2022.08.014_bb0050","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.lpm.2014.01.010","article-title":"Pathogenesis of immune thrombocytopenia","volume":"43","author":"Cines","year":"2014","journal-title":"Presse Med."},{"issue":"12","key":"10.1016\/j.thromres.2022.08.014_bb0055","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1182\/blood-2015-10-674531","article-title":"High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia","volume":"127","author":"Hou","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.08.014_bb0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1387-2656(06)12008-6","article-title":"Glucocorticoid action and the development of selective glucocorticoid receptor ligands","volume":"12","author":"Cole","year":"2006","journal-title":"Biotechnol. Annu. Rev."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2022.08.014_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.imlet.2013.08.006","article-title":"Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura","volume":"154","author":"Li","year":"2013","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.014_bb0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0609.2003.00138.x","article-title":"High Th1\/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura","volume":"71","author":"Ogawara","year":"2003","journal-title":"Eur. J. Haematol."},{"issue":"10","key":"10.1016\/j.thromres.2022.08.014_bb0075","article-title":"Treatments for primary immune thrombocytopenia: a review","volume":"11","author":"Samson","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.thromres.2022.08.014_bb0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2141.2006.06431.x","article-title":"High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura","volume":"136","author":"Emmerich","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2022.08.014_bb0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0609.2007.00917.x","article-title":"Circulating dendritic cells subsets and CD4+Foxp3+regulatory T cells inadult patients with chronic ITP before and after treatment with high-dose dexamethasome","volume":"79","author":"Ling","year":"2007","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.thromres.2022.08.014_bb0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/ACI.0000000000000116","article-title":"Mechanisms of immune regulation by IVIG","volume":"14","author":"Ballow","year":"2014","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.thromres.2022.08.014_bb0095","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2008-01-135335","article-title":"Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura","volume":"112","author":"Yu","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.08.014_bb0100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaci.2010.12.1102","article-title":"Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin","volume":"127","author":"Maddur","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.014_bb0105","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.hoc.2009.09.001","article-title":"Thrombopoietin and platelet production in chronic immune thrombocytopenia","volume":"23","author":"Kuter","year":"2009","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.014_bb0110","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/stemcells.2008-0366","article-title":"Preclinical activity of eltrombopag (SB497115), an oral, nonpeptide thrombopoietin receptor agonist","volume":"27","author":"Erickson-Miller","year":"2009","journal-title":"Stem Cells"},{"issue":"23","key":"10.1016\/j.thromres.2022.08.014_bb0115","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.014_bb0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12185-018-2445-z","article-title":"Chinese guidelines for treatment of adult primary immune thrombocytopenia","volume":"107","author":"Liu","year":"2018","journal-title":"Int. J. Hematol."},{"issue":"7","key":"10.1016\/j.thromres.2022.08.014_bb0125","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura is the manifestation of a type-1 polarized immune response","volume":"103","author":"Panitsas","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2022.08.014_bb0130","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","article-title":"Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T cell-reactivity","volume":"87","author":"Semple","year":"1996","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2022.08.014_bb0135","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","article-title":"IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation","volume":"23","author":"Liao","year":"2011","journal-title":"J. Curr. Opin. Immunol."},{"issue":"859","key":"10.1016\/j.thromres.2022.08.014_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1749-6632.1998.tb11113.x","article-title":"Experimental models to study molecular mechanisms underlying intestinal inflammation","volume":"17","author":"Elson","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.thromres.2022.08.014_bb0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1600-0609.2003.00138.x","article-title":"High Th1\/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura","volume":"71","author":"Ogawara","year":"2003","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.thromres.2022.08.014_bb0150","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cyto.2019.05.014","article-title":"Evaluation of IVIG response in relation to Th1\/Th2 cytokines in pediatricm immune thrombocytopenia","volume":"120","author":"Chen","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.thromres.2022.08.014_bb0155","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.biopha.2017.06.001","article-title":"Effect of intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL)","volume":"92","author":"Ahmadi","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.thromres.2022.08.014_bb0160","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood.V78.10.2619.2619","article-title":"Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia","volume":"78","author":"Semple","year":"1991","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2022.08.014_bb0165","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.4049\/jimmunol.169.10.5934","article-title":"A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance","volume":"169","author":"Goleva","year":"2002","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.014_bb0170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/iid3.249","article-title":"IL-2 modulates Th2 cell responses to glucocorticosteroid: a cause of persistent type 2 inflammation?","volume":"7","author":"Kanagalingam","year":"2019","journal-title":"Immun Inflamm Dis."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.014_bb0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/stem.5530130303","article-title":"Cytokines and autoantibodies to cytokines","volume":"13","author":"Bendtzen","year":"1995","journal-title":"Stem Cells"},{"key":"10.1016\/j.thromres.2022.08.014_bb0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/978-1-4614-3461-0_9","article-title":"Immunoregulation by naturally occurring and diseaseassociated autoantibodies: binding to cytokines and their role in regulation of T cell responses","volume":"750","author":"Nielsen","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.014_bb0185","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.4049\/jimmunol.179.8.5571","article-title":"Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function","volume":"179","author":"Kessel","year":"2007","journal-title":"J. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2022.08.014_bb0190","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/s10875-012-9762-4","article-title":"In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity","volume":"33","author":"Cousens","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2022.08.014_bb0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.clim.2015.08.005","article-title":"Potentiation of cytokine-induced proliferation of human natural killer cells by intravenous immunoglobulin G","volume":"161","author":"Issekutz","year":"2015","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.thromres.2022.08.014_bb0200","first-page":"493","article-title":"Assessment of Th17\/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model","volume":"22","author":"Zhang","year":"2017","journal-title":"Hematology"},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2022.08.014_bb0205","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1053\/j.seminhematol.2016.04.005","article-title":"T cells in the pathogenesis of immune thrombocytopenia","volume":"53","author":"Wei","year":"2016","journal-title":"Semin. Hematol."},{"issue":"4","key":"10.1016\/j.thromres.2022.08.014_bb0210","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12185-017-2392-0","article-title":"Circulating level of Th17 cells is associated with sensitivity to glucocorticoids in patients with immune thrombocytopenia","volume":"107","author":"Zhang","year":"2018","journal-title":"Int. J. Hematol."},{"issue":"5","key":"10.1016\/j.thromres.2022.08.014_bb0215","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.jaci.2018.07.019","article-title":"Glucocorticoids promote intrinsic human TH17 differentiation","volume":"142","author":"Kroner","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2022.08.014_bb0220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/cmi.2010.20","article-title":"Regulatory T cells: immune suppression and beyond","volume":"7","author":"Wan","year":"2010","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.014_bb0225","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MOH.0b013e32833eaef3","article-title":"Recent progress in understanding the pathogenesis of immune thrombocytopenia","volume":"17","author":"Semple","year":"2010","journal-title":"J. Curr. Opin. Hematol."},{"issue":"6","key":"10.1016\/j.thromres.2022.08.014_bb0230","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.thromres.2022.08.014_bb0235","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood-2007-06-094656","article-title":"Induction of FOXP3 expression in na\u00efve human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype","volume":"110","author":"Tran","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.08.014_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.thromres.2019.07.001","article-title":"The prediction value of treg cell subtype alterations for glucocorticoid treatment in newly diagnosed primary immune thrombocytopenia patients","volume":"181","author":"Cheng","year":"2019","journal-title":"Thromb. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822003565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:51:09Z","timestamp":1758736269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822003565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":48,"alternative-id":["S0049384822003565"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.08.014","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The short-term predictive value of CD4+ cells for combination therapy with high-dose dexamethasone and immunoglobulin in newly diagnosed primary immune thrombocytopenia patients","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}